VANGUARD GROUP INC 13D and 13G filings for Catalyst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 4:44 pm Sale | 2026-03-13 | 13G | CATALYST PHARMACEUTICALS INC. CPRX | VANGUARD GROUP INC | 0 0.000% | -7,120,417 (Position Closed) | Filing |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | CATALYST PHARMACEUTICALS INC. CPRX | VANGUARD GROUP INC | 7,120,417 6.680% | 351,676 (+5.20%) | Filing |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | CATALYST PHARMACEUTICALS INC. CPRX | VANGUARD GROUP INC | 6,768,741 6.500% | 1,932,428 (+39.96%) | Filing |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | CATALYST PHARMACEUTICALS INC. CPRX | VANGUARD GROUP INC | 4,836,313 4.690% | -934,766 (-16.20%) | Filing |